Showing results (201-210 of 781) with videos related to
Sort By:
Pageof 79
British Journal of Haematology|June 24, 2017
MUC1-C is a target in lenalidomide resistant multiple myelomaLi Yin, Ashujit Tagde, Reddy Gali, et al.Thescientificworldjournal|December 13, 2006
New frontiers in the treatment of multiple myelomaJanice Jin Hwang, Irene M Ghobrial, Kenneth C AndersonCancer Research|July 25, 2006
Proteasome inhibitor drugs on the riseClaudio A P Joazeiro, Kenneth C Anderson, Tony HunterBest Practice & Research. Clinical Haematology|July 20, 2005
Cytokines and signal transductionTeru Hideshima, Klaus Podar, Dharminder Chauhan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2005
Identification and validation of novel therapeutic targets for multiple myelomaTeru Hideshima, Dharminder Chauhan, Paul Richardson, et al.Medical Oncology (Northwood, London, England)|February 20, 2010
The evolution and impact of therapy in multiple myelomaJacob P Laubach, Paul G Richardson, Kenneth C AndersonHematology/Oncology Clinics of North America|November 13, 2007
Mouse models of human myelomaConstantine S Mitsiades, Kenneth C Anderson, Daniel R CarrascoExpert Opinion on Therapeutic Targets|June 7, 2005
Targeting signalling pathways for the treatment of multiple myelomaKlaus Podar, Teru Hideshima, Dharminder Chauhan, et al.Blood Reviews|August 7, 2002
Novel therapies for multiple myelomaJoan J Ryoo, Craig Emmitt Cole, Kenneth C AndersonNature Communications|January 6, 2016
The KDM3A-KLF2-IRF4 axis maintains myeloma cell survivalHiroto Ohguchi, Teru Hideshima, Manoj K Bhasin, et al.Pageof 79